Made possible by a grant from Baxter Healthcare Corporation, the effort called AKI!Now: Promoting Excellence in the Prevention and Treatment of Acute Kidney Injury, will aim to help people suffering from acute kidney injury (AKI).
“Each year, approximately 10 million people worldwide suffer from acute kidney injury, and it kills an estimated 1.75 million of them,” commented ASN President Mark Rosenberg, MD, FASN. “ASN is bringing together some of the best minds in the kidney community to figure out how we can save more lives after AKI and kidney failure as well as to improve their quality of life.”
Made possible by a grant from Baxter Healthcare Corporation, the effort called AKI!Now: Promoting Excellence in the Prevention and Treatment of Acute Kidney Injury, will aim to help people suffering from acute kidney injury (AKI).
“Each year, approximately 10 million people worldwide suffer from acute kidney injury, and it kills an estimated 1.75 million of them,” commented ASN President Mark Rosenberg, MD, FASN. “ASN is bringing together some of the best minds in the kidney community to figure out how we can save more lives after AKI and kidney failure as well as to improve their quality of life.”
Mortality and morbidity associated with AKI mortality are higher than for other common critical conditions, including acute respiratory distress syndrome and septic shock. The AKI!Now Steering Committee will review, analyze, and summarize the most recent evidence on AKI and engage all relevant stakeholders to identify the most promising interventions and treatments. The next phase will be to educate the medical community on early recognition, effective interventions, best practices, and treatment pathways.
“The ICU patient population can be difficult to study, given high mortality and morbidity, and the complexity of their care. Those factors make it hard to identify best practices for treating critically ill patients,” said Sumant Ramachandra, MD, PhD, MBA, chief science and technology officer, Baxter. “This initiative will provide important guidance on effective diagnosis and treatment protocols and, ultimately, advance care for the millions of patients impacted by AKI each year.”
“Some progress has been made, but much remains to be done to advance the fight against acute kidney failure,” said Jorge Cerdá, MD, FASN, AKI!Now Steering Committee member. “Our goal is to stop kidney failure from happening in the first place for millions of people.”
The AKI!Now Steering Committee includes:
- Jorge Cerdá, MD, MS, FASN, Chair – Albany Medical College
- Anupam Agarwal, MD, FASN – University of Alabama at Birmingham School of Medicine
- Stuart Goldstein, MD, FASN – Cincinnati Children’s Hospital Medical Center
- Kathleen D. Liu, MD, PhD, FASN – University of California, San Francisco, School of Medicine
- Mark D. Okusa, MD, FASN – University of Virginia School of Medicine
- Anitha Vijayan, MD, FASN – Washington University School of Medicine
For more information,
please see the ASN Press Release
.
If you are interested in learning more or getting involved, please contact Susie Stark at sstark@asn-online.org .
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory